Patients with rheumatologic conditions (ie: RA, EGPA, and SLE) are often immunocompromised because of abnormalities in their immune system related to their disease or as a result of the immunosuppressive effects of their treatments. Managing the immunocompromised rheumatologic patient can be challenging and complex. Join Prof. Calabrese and Prof. Winthrop as they discuss a holistic approach to identifying and managing these patients through a case analysis. Developed and offered by GSK.
Non-CME
